Many cases of MIDY and MODY require insulin therapy, however, MODY 1 and MODY 3, caused by mutations in the transcription factors hepatocyte nuclear factor 4α (HNF4A) and 1α (HNF1A), respectively, can often improve insulin secretion with sulfonylurea treatment. This evidence concerns the gene HNF4A and MODY.